Effect of two monophasic oral contraceptives containing gestodene or desogestrel on serum lipoprotein lipid levels. 1989

J A Leuven, and H A de Pagter, and M A Dersjant-Roorda, and F A Helmerhorst, and J Roelofsen
Gaubius Institute TNO, Leiden, The Netherlands.

Forty-nine healthy women aged 20-35 years who had not been pregnant or using an oral contraceptive (OC) for the previous 3 months were randomized into two groups, one group taking an OC containing 75 micrograms gestodene (GTD) and 30 micrograms ethinyl estradiol (EE), and the other group using an OC with 150 micrograms desogestrel (DSG) and 30 micrograms EE. Fasting blood samples were taken before treatment, and after cycles 3 and 6, between the 18th and the 22nd day of the cycle. Blood lipoprotein lipid levels were measured. Serum total cholesterol did not change significantly in both groups. However, in the first three cycles, serum triglyceride increased by 46% and 40% and HDL-cholesterol by 14% and 8% in the GTD and DSG groups, respectively. The serum LDL level decreased by 6.2% and 11.8%, respectively. Between the third and sixth cycle, no further significant changes were observed, nor did these changes differ significantly between the two groups. In conclusion, both OC preparations exerted small and probably favorable effects on serum lipoprotein lipid levels.

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D009652 Norpregnenes Pregnenes with one double bond or more than three double bonds which have undergone ring contractions or are lacking carbon-18 or carbon-19..
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003277 Contraceptives, Oral, Combined Fixed drug combinations administered orally for contraceptive purposes. Combined Oral Contraceptive,Contraceptive Agents, Female, Combined,Oral Contraceptives, Combined,Combined Oral Contraceptives,Contraceptive, Combined Oral,Contraceptives, Combined Oral,Oral Contraceptive, Combined
D004997 Ethinyl Estradiol A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-,Ethynyl Estradiol,Estinyl,Ethinyl Estradiol Hemihydrate,Ethinyl Estradiol, (8 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer,Ethinyl Estradiol, (9 beta,17 alpha)-Isomer,Ethinyl-Oestradiol Effik,Ethinylestradiol Jenapharm,Ethinyloestradiol,Lynoral,Microfollin,Microfollin Forte,Progynon C,Estradiol, Ethinyl,Estradiol, Ethynyl,Ethinyl Oestradiol Effik,Hemihydrate, Ethinyl Estradiol,Jenapharm, Ethinylestradiol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J A Leuven, and H A de Pagter, and M A Dersjant-Roorda, and F A Helmerhorst, and J Roelofsen
September 1998, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception,
J A Leuven, and H A de Pagter, and M A Dersjant-Roorda, and F A Helmerhorst, and J Roelofsen
June 2004, Contraception,
J A Leuven, and H A de Pagter, and M A Dersjant-Roorda, and F A Helmerhorst, and J Roelofsen
April 2000, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
J A Leuven, and H A de Pagter, and M A Dersjant-Roorda, and F A Helmerhorst, and J Roelofsen
April 1995, Contraception,
J A Leuven, and H A de Pagter, and M A Dersjant-Roorda, and F A Helmerhorst, and J Roelofsen
September 1989, International journal of fertility,
J A Leuven, and H A de Pagter, and M A Dersjant-Roorda, and F A Helmerhorst, and J Roelofsen
August 1998, Contraception,
J A Leuven, and H A de Pagter, and M A Dersjant-Roorda, and F A Helmerhorst, and J Roelofsen
August 2008, Expert opinion on pharmacotherapy,
J A Leuven, and H A de Pagter, and M A Dersjant-Roorda, and F A Helmerhorst, and J Roelofsen
April 1985, Contraception,
J A Leuven, and H A de Pagter, and M A Dersjant-Roorda, and F A Helmerhorst, and J Roelofsen
November 1993, American journal of obstetrics and gynecology,
J A Leuven, and H A de Pagter, and M A Dersjant-Roorda, and F A Helmerhorst, and J Roelofsen
January 1995, International journal of fertility and menopausal studies,
Copied contents to your clipboard!